webleads-tracker

EFPIA

EFPIA : Pharmaceutical companies drive transparency and underline industry investment in European Healthcare

Sunshine Act

Over the next ten days, pharmaceutical companies will be disclosing details of collaborations with health professionals (HCPs) and healthcare organisations (HCOs) across Europe. The figures, which will be available online, underline industry’s investment in European healthcare, enabling the development of new medicines through sharing best clinical practice, exchanging information on how new medicines fit into the patient pathway and shaping the future of clinical research. Director General of EFPIA, Richard Bergström said, “Increasing transparency through the individual disclosure of transfers of value is good for everyone, including healthcare professionals because it builds understanding of this important collaboration.  When pharmaceutical companies …

Read More »

Publications EFPIA : au tour de la Belgique

Pour la première fois, des montants octroyés par les sociétés pharmaceutiques faisant partie de Pharma.be à des médecins, infirmiers, pharmaciens ou organismes et associations ayant trait à la santé seront rendus publics et donc accessibles à tous. Ce mercredi en effet, sont dès à présent publiés sur betransparent.be ce que l’on appelle les « transferts de valeurs » pour l’année 2015. Certes, après des années d’opacité et de soupçons parfois avérés sur les transactions opérées entre l’industrie pharmaceutique et certains professionnels de la santé, la législation et des codes de déontologie ont remis un peu d’ordre bien nécessaire. Mais en l’occurrence, c’est …

Read More »

Publications EFPIA : Finlande, Norvège et Suède sont les premiers

Sunshine Act

La Finlande, la Norvège et la Suède sont les premiers pays pour lesquels les entreprises pharmaceutiques ont publié leurs liens d’intérêts conformément au Disclosure Code EFPIA. Les données de la Finlande sont regroupées sur le site de Pharma Industry Finland (PIF) Celles de la Suède sur le site de Swedish Association of the Pharmaceutical Industry (LIF) Les données de la Norvège sont publiées par chaque laboratoire pharmaceutique sur leur propre site

Read More »

EFPIA Disclosure “Sunshine Act – Lite”

Transparence santé, Sunshine Act

Thomas Sullivan, April 13, 2016. For the first time, on June 30, 2016, pharmaceutical companies will be forced to disclose full data on payments made to doctors across Europe. Starting then, all pharmaceutical companies will be required to publish payments they made in the previous year to physicians, nurses, and other healthcare professionals (HCPs), identifying them by name when possible. The rules will also encompass payments made to hospitals and other healthcare organizations (HCOs) across thirty-three European countries. This move is huge for the industry’s relationship with doctors, and reflects a global move toward greater transparency – for better or …

Read More »

UK’s Version of EFPIA Disclosure: Bred with the Sunshine Act in Mind

Transparence santé, Sunshine Act

Thomas Sullivan, April 13, 2016. While this move was prompted by EFPIA (the European Federation of Pharmaceutical Industries and Associations), thirty-three countries in Europe will apply the transparency goals and recommendations in different ways. Some countries are opting for a central platform database similar to the UK database, and others will allow for payment disclosures to be made on company’s own websites. Some countries (i.e., France, Slovakia, Greece, Romania) have even passed legislation to make disclosures of payments to healthcare professionals mandatory. ABPI believes that while the EFPIA requirement only mandates that payment information be available on the relevant Member …

Read More »